Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Gary Veron
ID:
1b834081-2619-30fb-68c4
/
Unclaimed
/
Organization:
Hogan Lovells
Published Works
9 articles
FDA Denies Three Petitions on Biosimilar Labeling: Refers Petitioners to Guidance Process
Biosimilars Law Blog ·
July 15, 2016
cite
FDA Guidance on Transition Biological Products: Implications for Exclusivity and Patent Listings
Biosimilars Law Blog ·
March 16, 2016
cite
FDA Guidance on Transition Biological Products: Implications for Exclusivity and Patent Listings
Focus on Regulation ·
March 16, 2016
cite
FDA revises forms for submission of patent information to the Orange Book: Federal Circuit decision in Novartis AG v. Lee alters patent term adjustment
Focus on Regulation ·
February 27, 2014
cite
Previous
1
2
Next
